Shijun Lv

1.7k total citations · 1 hit paper
33 papers, 1.3k citations indexed

About

Shijun Lv is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Shijun Lv has authored 33 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Oncology and 7 papers in Cancer Research. Recurrent topics in Shijun Lv's work include Peptidase Inhibition and Analysis (5 papers), Cancer-related molecular mechanisms research (5 papers) and Cancer Mechanisms and Therapy (5 papers). Shijun Lv is often cited by papers focused on Peptidase Inhibition and Analysis (5 papers), Cancer-related molecular mechanisms research (5 papers) and Cancer Mechanisms and Therapy (5 papers). Shijun Lv collaborates with scholars based in China, United States and Japan. Shijun Lv's co-authors include Wentong Li, Mengyu Yu, Jie Zheng, Chengcheng Gai, Weifen Zhang, Dejun Ding, Chuanliang Liu, Yonghong Sun, Pengyun Qiao and Chune Ren and has published in prestigious journals such as Cancer Research, Oncogene and Brain Research.

In The Last Decade

Shijun Lv

32 papers receiving 1.3k citations

Hit Papers

Targeted exosome‐encapsulated erastin induced ferroptosis... 2019 2026 2021 2023 2019 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shijun Lv China 17 868 656 427 203 111 33 1.3k
Ying Shen China 18 836 1.0× 579 0.9× 471 1.1× 223 1.1× 75 0.7× 55 1.4k
Yongchun Zhou China 25 941 1.1× 682 1.0× 327 0.8× 328 1.6× 114 1.0× 80 1.6k
Yuan‐Feng Lin Taiwan 22 924 1.1× 446 0.7× 192 0.4× 251 1.2× 143 1.3× 71 1.4k
Danilo Fiore Italy 16 898 1.0× 776 1.2× 225 0.5× 216 1.1× 105 0.9× 26 1.5k
Corinne Godin France 14 1.1k 1.3× 929 1.4× 1.1k 2.6× 321 1.6× 75 0.7× 22 1.7k
Jiang Zhu China 21 692 0.8× 515 0.8× 168 0.4× 177 0.9× 75 0.7× 75 1.2k
Mingzhi Han China 21 795 0.9× 429 0.7× 258 0.6× 215 1.1× 154 1.4× 39 1.2k
JiHoon Kang South Korea 21 642 0.7× 476 0.7× 275 0.6× 493 2.4× 100 0.9× 63 1.4k

Countries citing papers authored by Shijun Lv

Since Specialization
Citations

This map shows the geographic impact of Shijun Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shijun Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shijun Lv more than expected).

Fields of papers citing papers by Shijun Lv

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shijun Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shijun Lv. The network helps show where Shijun Lv may publish in the future.

Co-authorship network of co-authors of Shijun Lv

This figure shows the co-authorship network connecting the top 25 collaborators of Shijun Lv. A scholar is included among the top collaborators of Shijun Lv based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shijun Lv. Shijun Lv is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Xi, Fei Song, Peng Xiao, et al.. (2025). Spermine accumulation via spermine synthase promotes tumor cell proliferation in head and neck squamous cell carcinoma. BMC Cancer. 25(1). 402–402. 1 indexed citations
2.
Li, Wentong, et al.. (2023). Pseudolaric acid B triggers ferritinophagy and ferroptosis via upregulating NCOA4 in lung adenocarcinoma cells. Journal of Cancer Research and Therapeutics. 19(6). 1646–1653. 7 indexed citations
3.
Zhou, Dandan, Hongli Li, Wei Liu, et al.. (2021). miR‐193a‐3p Promotes the Invasion, Migration, and Mesenchymal Transition in Glioma through Regulating BTRC. BioMed Research International. 2021(1). 8928509–8928509. 13 indexed citations
4.
Lü, Chao, Chune Ren, Tingting Yang, et al.. (2020). A Noncanonical Role of Fructose-1, 6-Bisphosphatase 1 Is Essential for Inhibition of Notch1 in Breast Cancer. Molecular Cancer Research. 18(5). 787–796. 24 indexed citations
5.
Gai, Chengcheng, Chuanliang Liu, Xinghan Wu, et al.. (2020). MT1DP loaded by folate-modified liposomes sensitizes erastin-induced ferroptosis via regulating miR-365a-3p/NRF2 axis in non-small cell lung cancer cells. Cell Death and Disease. 11(9). 751–751. 189 indexed citations
6.
Yang, Tingting, Chune Ren, Chao Lü, et al.. (2019). Phosphorylation of HSF1 by PIM2 Induces PD-L1 Expression and Promotes Tumor Growth in Breast Cancer. Cancer Research. 79(20). 5233–5244. 72 indexed citations
7.
Yang, Tingting, Chune Ren, Pengyun Qiao, et al.. (2019). Correction: PIM2-mediated phosphorylation of hexokinase 2 is critical for tumor growth and paclitaxel resistance in breast cancer. Oncogene. 39(3). 720–721. 85 indexed citations
8.
Li, Hongli, Zhiyi Yang, Zhaoyan Wang, et al.. (2019). MiR-486-5p inhibits IL-22-induced epithelial-mesenchymal transition of breast cancer cell by repressing Dock1. Journal of Cancer. 10(19). 4695–4706. 36 indexed citations
9.
Gai, Chengcheng, Mengyu Yu, Yonghong Wang, et al.. (2019). Acetaminophen sensitizing erastin‐induced ferroptosis via modulation of Nrf2/heme oxygenase‐1 signaling pathway in non‐small‐cell lung cancer. Journal of Cellular Physiology. 235(4). 3329–3339. 130 indexed citations
10.
Yang, Tingting, Chune Ren, Pengyun Qiao, et al.. (2018). PIM2-mediated phosphorylation of hexokinase 2 is critical for tumor growth and paclitaxel resistance in breast cancer. Oncogene. 37(45). 5997–6009. 101 indexed citations
11.
Li, Wentong, Chuanliang Liu, Chunling Zhao, Limin Zhai, & Shijun Lv. (2016). Downregulation of β3 integrin by miR-30a-5p modulates cell adhesion and invasion by interrupting Erk/Ets-1 network in triple-negative breast cancer. International Journal of Oncology. 48(3). 1155–1164. 45 indexed citations
12.
Zhang, Hongxia, Weili Luo, Yonghong Sun, et al.. (2016). Wnt/β-Catenin Signaling Mediated-UCH-L1 Expression in Podocytes of Diabetic Nephropathy. International Journal of Molecular Sciences. 17(9). 1404–1404. 33 indexed citations
13.
Li, Wentong, Limin Zhai, Chunling Zhao, & Shijun Lv. (2015). miR-153 inhibits epithelial–mesenchymal transition by targeting metadherin in human breast cancer. Breast Cancer Research and Treatment. 150(3). 501–509. 44 indexed citations
14.
Li, Wentong, Baogang Zhang, Hongli Li, et al.. (2014). TGF β1 Mediates Epithelial Mesenchymal Transition via β6 Integrin Signaling Pathway in Breast Cancer. Cancer Investigation. 32(8). 409–415. 10 indexed citations
15.
Liu, Ying, Wenwu Liu, Xuejun Sun, et al.. (2011). Hydrogen saline offers neuroprotection by reducing oxidative stress in a focal cerebral ischemia-reperfusion rat model. Medical Gas Research. 1(1). 15–15. 34 indexed citations
16.
Zhang, Minghu, et al.. (2011). Research on the Multi-Sensors Fusion System in Warships Chemical Detection Field. Sensor Letters. 9(5). 2104–2108. 1 indexed citations
17.
Li, Wentong, Chuanliang Liu, Yong Tang, et al.. (2011). Overexpression of Snail accelerates adriamycin induction of multidrug resistance in breast cancer cells.. PubMed. 12(10). 2575–80. 38 indexed citations
18.
Lv, Shijun, et al.. (2010). Output Torque of Double-acting Multi-pump and Multi-motor. 21(23). 2836–2838. 1 indexed citations
19.
Zhang, Minghu, et al.. (2009). Research on grey modeling means and its application. 27. 425–428. 1 indexed citations
20.
Li, Zhang, Wenwu Liu, Zhimin Kang, et al.. (2008). Mechanism of hyperbaric oxygen preconditioning in neonatal hypoxia–ischemia rat model. Brain Research. 1196. 151–156. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026